Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04260022
Title Study of HQP1351 in Subjects With Refractory Chronic Myeloid Leukemia (HQP1351CU101)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ascentage Pharma Group Inc.
Indications

myeloid leukemia

chronic myeloid leukemia

Therapies

HQP1351

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.